Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | IGF1R | P08069 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | ERCC1 | P07992 | 3/20 | 0.50 |
| ▸ | ERCC4 | Q92889 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | HRAS | P01112 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107957 | 0.81 | ARG1 (0.63) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL17065239 | 0.79 | ARG1 (0.61) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL8297694 | 0.79 | ARG1 (0.61) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL29559774 | 0.78 | MAPT (0.66) | CA1CA2CA4CA6ALOX15 | |
| SCHEMBL14970857 | 0.77 | ARG1 (0.59) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL13781413 | 0.77 | MAPT (0.64) | ARG1CA1CA2CA4CA6 | |
| Bromide SCHEMBL15398307 | 0.76 | MAPT (0.62) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL6718210 | 0.76 | ARG1 (0.57) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL12471961 | 0.74 | TRPA1 (0.59) | ARG1CA1CA2CA4CA6 | |
| SCHEMBL175299 | 0.74 | ERCC1 (0.66) | ARG1ERCC1ERCC4ALPLALPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703822-B2 | Method for removing undifferentiated and dedifferentiated stem cell | NANYANG POLYTECHNIC (SG) | 2014-04-22 | — | — | US | disclosed |
| US-20120083532-A1 | NOVEL USES | NANYANG POLYTECHNIC (SG) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083532-A1 | NOVEL USES | PYCR1, CYP11B2, IL4I1 | ARG1 918/4885CA1 639/4885CA2 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.